Should patients with acute ST elevation MI be transferred for primary PCI?

Heart

Volumn 90, Issue 11, 2004, Pages 1358-1363

  Kristensen, Steen Dalby ^a,b   Andersen, H R ^b   Thuesen, L ^b   Krusell, L R ^b   Botker H E ^b   Lassen, J F ^b   Nielsen, T T ^b  

^a Skeiby Sygehus   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; PLASMINOGEN ACTIVATOR; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

ACUTE HEART INFARCTION; CARDIOGENIC SHOCK; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HUMAN; MORTALITY; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; TELECOMMUNICATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS; HUMANS; MYOCARDIAL INFARCTION; PATIENT TRANSFER; THROMBOLYTIC THERAPY;

EID: 7244257422     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.021881     Document Type: Review

References (19)

1. Boersma E, Mercado N, Poldermans D, et al. Acute myocardial infarction. Lancet 2003;361:847-58. Excellent recent review on epidemiology, diagnosis, and treatment of acute myocardial infarction.
2. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003;24:28-66. The current European Society of Cardiology guidelines, accepted for publication in August 2002.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. Recent meta-analysis conducted on all randomised trials comparing primary PCI to thrombolysis and also a separate meta-analysis on the transfer trials.
4. Vermeer F, Oude Ophuis AJM, van den Berg EJ, et al. Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999;82:426-31.
5. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-31.
6. Grines CL, Westerhausen DR Jr, Grines LL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002;39:1713-9.
7. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Eur Heart J 2003;24:94-104. Second largest single study an streptokinase versus transferral for primary PCI, showing a trend towards decreased mortality in those patients transferred for primary PCI.
8. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42. The largest and mast recent study an alteplase versus primary PCI, including a separate study showing that transferral to a tertiary centre for primary PCI is superior to thrombolysis given in the local hospital.
9. Andersen HR, Nielsen TT, Vesterlund T, et al. The Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANAMI-2 trial. Am Heart J 2003;146:234-41.
10. Dalby M, Bouzamando A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction. Circulation 2003;108:1809-14. Recent meta-analysis of the five transferral trials (references 4-8 in this paper) and the CAPTIM trial.
11. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-29. The first publication an the French CAPTIM study showing a non-significant trend towards a better outcome in the primary PCI group compared to pre-hospital alteplase.
12. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators: should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:625-34. Randomised trial showing that patients aged < 75 years with cardiogenic shock benefit from an invasive strategy with PCI or coronary artery bypass graft surgery.
13. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome in patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23:550-7.
14. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
15. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction. JAMA 2000;283:2686-92. Meta-analysis suggesting that pre-hospital thrombolysis decreases time to thrombolysis and all cause mortality compared to in-hospital thrombolysis.
16. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation 2003;108:2851-6. This paper reports the results of subgroup analysis of the CAPTIM study-a trend towards a better outcome for pre-hospital thrombolysis compared to transferral for primary PCI was found in patients with a duration of symptoms < 2 hours.
17. Topol EJ, Neumann FJ, Montalescot G. A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 2003;42:1886-9. Review and meta-analysis suggesting that the use of the platelet glycoprotein IIb/IIIa inhibitor abciximab improves outcome in patients undergoing primary PCI.
18. Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator angioplasty compatibility trial. J Am Coll Cardiol 1999;34:1954-62.
19. Kastrati A, Mehilli J, Schotterbeck K, et al. Early administration of reteplase plus abcixiab vs abciximab alone in patients with acute myocardial infarction referrel far percutaneous coronary intervention. JAMA 2004;291:947-54.